Chartwell Investment Partners, LLC Relmada Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$29.88 - $39.8 $218,960 - $291,654
-7,328 Closed
0 $0
Q2 2020

Jul 29, 2020
SELL
$31.59 - $49.98 $68,044 - $107,656
-2,154 Reduced 22.72%
7,328 $328,000
Q1 2020

Apr 30, 2020
BUY
$23.78 - $50.12 $16,693 - $35,184
702 Added 8.0%
9,482 $323,000
Q4 2019

Jan 29, 2020
BUY
$10.1 - $47.18 $88,678 - $414,240
8,780 New
8,780 $342,000

Others Institutions Holding RLMD

# of Institutions
54
Shares Held
8.29M
Call Options Held
364K
Put Options Held
46.5K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $7.72M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email